RxDoctor Payments Data

Ramakanth Yakkanti, MD

Orthopaedic Surgery · Winter Park, FLNPI 1679004774

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (43.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 63.5% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2023 at $4,303 and has fallen 60.7% since, to $1,691 in 2025.

$11,595in general payments, 2019–2025

Across 74 payments — averaging $156.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$7K
  • Stryker$3K
  • Johnson & Johnson$191
  • Zimmer Biomet$190
  • Davol Inc.$168
  • Next Science LLC$104
  • plus $380 from 9 others

What the payments were for

  • Travel & lodging$1,79015%
  • Food & beverage$4,80641%
  • Education$5,00043%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,595 in reported general payments places this provider in the 65th percentile of 1,263 orthopaedic surgery providers in Florida.

See all orthopaedic surgery providers in Florida →

Medicare billing

Part B allowed, 2024
$154,580
Medicare patients
302
Services billed
2,054

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam166$381
Diclofenac Sodium13$216
Oxycodone Hcl15$52

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Winter Park

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →